The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | DDisposition to issuer Ordinary Shares | -124,414 | - | - | 89,062 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | DDisposition to issuer Ordinary Shares | -89,062 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | DDisposition to issuer Share Option (Right to Buy)derivative | -150,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Ordinary Shares | -42,137 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -32,666 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Susannah Gray director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Ordinary Shares | -74,204 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Donal O'Connor director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Ordinary Shares | -74,980 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,500 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Alsup Laurie Smaldone director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Shares | -1,382,272 | - | - | 228,750 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Shares | -151,875 | - | - | 76,875 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Shares | -76,875 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Sharesindirect: As Custodian | -23,400 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Ordinary Sharesindirect: By Trust | -92,567 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Rick E Winningham CHIEF EXECUTIVE OFFICER | DDisposition to issuer Share Option (Right to Buy)derivative | -515,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Ordinary Shares | -58,065 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -17,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Ordinary Shares | -91,204 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.